lazucirnon (AKST4290) - Grifols
Rituxan (rituximab) - Roche
Coversin SC (nomacopan SC) - Akari Therap
Xolair (omalizumab) - Roche, Novartis
bertilimumab (iCo-008) - Satellos Biosci
Fasenra (benralizumab) - AstraZeneca
Dupixent (dupilumab) - Sanofi, Regeneron
avdoralimab (IPH5401) - Innate
Vyvgart (efgartigimod alfa-fcab) - argenx, Broteio
http://www.ncbi.nlm.nih.gov/pubmed/40878514
 
Christian D Sadik; Henning Olbrich
 
Aug 29, 2025
 
Prev Next